Effects of multiple treatments with stem cell therapy in patients with multiple sclerosis
This study analyzed clinical trial data to compare the effectiveness of autologous hematopoietic stem cell transplantation (AHSCT) and mesenchymal stem cells (MSCs) against non-stem cell therapies in multiple sclerosis (MS) patients. Findings suggest that certain stem cell treatments may help reduce relapse rates and improve disability outcomes, though results vary based on therapy type.
How MSC-Exosomes and Ginsenoside Rh2 Are Shaping the Future of Rheumatoid Arthritis
A study on collagen-induced arthritis explores the combined use of mesenchymal stem cell-derived exosomes (MSC-exosomes) and ginsenoside Rh2. The results suggest that this combination can influence macrophage polarization and pyroptosis, offering new perspectives on rheumatoid arthritis treatment.
Exploring the Role of Exosomes in Managing Diabetes Mellitus
Mesenchymal stem cell (MSC)-derived exosomes are being explored as a potential treatment for diabetes mellitus (DM). These exosomes show promise in improving pancreatic function and reducing insulin resistance, offering a cell-free alternative to traditional stem cell therapies.
